These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4713570)

  • 1. Reduced peritoneal clearances in scleroderma increased by intraperitoneal isoproterenol.
    Brown ST; Ahearn DJ; Nolph KD
    Ann Intern Med; 1973 Jun; 78(6):891-4. PubMed ID: 4713570
    [No Abstract]   [Full Text] [Related]  

  • 2. Peritoneal clearances in scleroderma and diabetes mellitus: effects of intraperitioneal isoproterenol.
    Nolph KD; Miller L; Husted FC; Hirszel P
    Int Urol Nephrol; 1976; 8(2):161-9. PubMed ID: 965210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoproterenol enhancement of peritoneal permeability.
    Maher JF; Shea C; Cassetta M; Hohnadel DC
    J Dial; 1977; 1(4):319-31. PubMed ID: 608855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of intraperitoneal vasodilators on peritoneal clearances.
    Nolph KD; Ghods AJ; Van Stone J; Brown PA
    Trans Am Soc Artif Intern Organs; 1976; 22():586-94. PubMed ID: 951875
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the effects of lactate and acetate on clinical peritoneal clearances.
    Rubin J; Nolph KD; Arfaania D; Wiegman DL; Miller FN; Harris PD
    Clin Nephrol; 1979 Oct; 12(4):145-7. PubMed ID: 509789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated peritoneal dialysis with intraperitoneal isoproterenol.
    Vanichayakornkul S; Nimmannit S; Chirawong P; Nilwarangkur S
    J Med Assoc Thai; 1978 Jan; 61 Suppl 1():127-30. PubMed ID: 627785
    [No Abstract]   [Full Text] [Related]  

  • 7. The relationship between the clearances of urea and creatinine in peritoneal dialysis.
    Tzamaloukas AH; Murata GH; Malhotra D
    Int J Artif Organs; 1998 May; 21(5):255-8. PubMed ID: 9684906
    [No Abstract]   [Full Text] [Related]  

  • 8. Peritoneal transfer of kanamycin and its use in peritoneal dialysis.
    Atkins RC; Mion C; Despaux E; Nguyen-Van-Hai ; Julien C; Mion H
    Kidney Int; 1973 Jun; 3(6):391-6. PubMed ID: 4791143
    [No Abstract]   [Full Text] [Related]  

  • 9. Peritoneal urea and creatinine clearances in continuous peritoneal dialysis patients with different types of peritoneal solute transport.
    Tzamaloukas AH; Murata GH; Piraino B; Rao P; Bernardini J; Malhotra D; Oreopoulos DG
    Kidney Int; 1998 May; 53(5):1405-11. PubMed ID: 9573559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transperitoneal solute movement in children.
    Gruskin AB; Rosenblum H; Baluarte HJ; Morgenstern BZ; Polinsky MS; Perlman SA
    Kidney Int Suppl; 1983 Nov; 15():S95-100. PubMed ID: 6584681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal dialysis in rabbits. A study of transperitoneal theophylline flux and peritoneal permeability.
    Maher JF; Cassetta M; Shea C; Hohnadel DC
    Nephron; 1978; 20(1):18-23. PubMed ID: 619296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous ambulatory peritoneal dialysis and scleroderma.
    Copley JB; Smith BJ
    Nephron; 1985; 40(3):353-6. PubMed ID: 4010851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intraperitoneal and intravenous vasoactive amines on peritoneal dialysis: study in anephric dogs.
    Gutman RA; Nixon WP; McRae RL; Spencer HW
    Trans Am Soc Artif Intern Organs; 1976; 22():570-4. PubMed ID: 951874
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of calcium antagonists on the peritoneal membrane in patients on CAPD.
    Vargemezis V; Pasadakis P; Thodis E
    Adv Perit Dial; 1989; 5():8-11. PubMed ID: 2577433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasma proteins in patients on weekly peritoneal dialysis and hypercaloric and hyperproteinic diet, using vasoactive drugs].
    Treviño Becerra A; Velazquez Gómez H; Paniagua R; Gutiérrez Vega ML
    Prensa Med Mex; 1978; 43(9-10):272-7. PubMed ID: 757614
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of pharmacologic agents on transperitoneal elimination of low-molecular compounds during peritoneal dialysis].
    Grzegorzewska A
    Pol Arch Med Wewn; 1989; 82(2-3):65-70. PubMed ID: 2638739
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanisms for inefficient peritoneal dialysis in acute renal failure associated with heat stress and exercise.
    Nolph KD; Whitcomb ME; Schrier RW
    Ann Intern Med; 1969 Aug; 71(2):317-36. PubMed ID: 5800295
    [No Abstract]   [Full Text] [Related]  

  • 18. Adequacy of solute and water removal in children treated with nightly intermittent peritoneal dialysis.
    Edefonti A; Picca M; Ghio L; Bassi S; Cattarelli D; Leccese V
    Adv Perit Dial; 1992; 8():402-5. PubMed ID: 1361833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal blood flow and peritoneal transfer parameters during dialysis with administration of drugs.
    Grzegorzewska AE; Antoniewicz K
    Adv Perit Dial; 1995; 11():28-32. PubMed ID: 8534723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential clearance and dialysance measurements in chronic peritoneal dialysis patients.
    Finkelstein FO; Kliger AS; Bastl C; Yap P
    Nephron; 1977; 18(6):342-7. PubMed ID: 876441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.